Intensive follow-up strategies after radical surgery for nonmetastatic colorectal cancer: A systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Intensive follow-up strategies after radical surgery for nonmetastatic colorectal cancer: A systematic review and meta-analysis of randomized controlled trials

Published:2019-07-30 Issue:7 Volume:14 Page:e0220533
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zhao Yaqin,Yi Cheng,Zhang Yu,Fang Fang^ORCID,Faramand Andrew

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference46 articles.

1. Cancer statistics, 2018;RL Siegel;CA: a cancer journal for clinicians,2018

2. Is curative resection and long-term survival possible for locally re-recurrent colorectal cancer in the pelvis?;DT Colibaseanu;Dis Colon Rectum,2013

3. Routine surgical follow up: do surgeons agree?;A Waghorn;BMJ (Clinical research ed),1995

4. Cost of patient follow-up after potentially curative colorectal cancer treatment;KS Virgo;Jama,1995

5. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;B Glimelius;Ann Oncol,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association of cognitive coping style with patient preferences in a patient-led follow-up study among colorectal cancer survivors;Supportive Care in Cancer;2024-08

2. Early follow‐up colonoscopy after colorectal cancer resection detects significant pathology;ANZ Journal of Surgery;2024-07

3. The association of Cognitive Coping Style with Patient Preferences in a Patient- Led Follow-Up Study among Colorectal Cancer Survivors;2024-03-18

4. Intensive follow-up vs conventional follow-up for patients with non-metastatic colorectal cancer treated with curative intent: A meta-analysis;World Journal of Gastrointestinal Oncology;2023-12-15

5. Effect of High-Versus Low-Frequency of Abdominopelvic Computed Tomography Follow-Up Testing on Overall Survival in Patients With Stage II Or III Colon Cancer;Clinical Colorectal Cancer;2023-09